T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives
about
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes MellitusImmune therapy in type 1 diabetes mellitusT cells recognizing a peptide contaminant undetectable by mass spectrometry.On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes.Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes.Novel autoantigens in type 1 diabetes.The role of MIF in type 1 and type 2 diabetes mellitus.Prevention or acceleration of type 1 diabetes by viruses.The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.Do post-translational beta cell protein modifications trigger type 1 diabetes?A peptide's perspective on antigen presentation to the immune system.Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective.Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.Role of TGF-β in Self-Peptide Regulation of Autoimmunity.Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response.Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy.Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
P2860
Q26796516-181FCCAD-ACE7-4988-8D11-09839E4972A4Q28282846-5800E0CE-287D-4BD9-A51A-BB1B7883D6E6Q34110455-F29ADCB5-FB25-4966-B487-A415B32257A4Q34150236-13B906E0-C24B-4A97-8D84-2FD9F69C3222Q35640553-8545EA0A-86E5-485B-80DA-9FCBE6C7135CQ36010973-55507394-F3E3-42AA-B913-EFCFD00715AFQ36881807-DFCDEE43-03C1-400E-87A0-37EA24345A7AQ37542812-652F9902-E414-43B6-8CBF-A9C67B16B7CDQ38024272-AC799EFF-CAE8-4A13-BFC7-1612D81D8DF2Q38134108-6B109FDD-BF3A-4A8F-833C-812F3804E8CEQ38134730-910162E9-DE6E-4C4B-850E-28BD781BC868Q38135862-652A8F03-0535-46D9-9C76-1B9C6EDDF613Q38139283-3E24858D-9008-448F-AA33-977523E80D27Q38162671-8792F445-68D2-46A8-B597-5A69E13CCA14Q38189119-4E36BE93-C221-44F3-8368-1D6F886CD6D0Q38983184-C293C6C5-BDAC-45A4-B9C1-BC04E84CD850Q39451535-C306A68F-025F-4A51-95BF-0A19397CB250Q49200196-FA5F90FC-C42F-43E5-93F9-5DBF76B76D42Q52316229-467BCB29-8E34-4315-971B-2962F74F34DAQ52680553-BEB1F0A0-063F-402C-94EB-11B27BE89388Q58773667-EC1CF002-9820-460C-BE5D-F7D3B152ABAE
P2860
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives
@en
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
@nl
type
label
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives
@en
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
@nl
prefLabel
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives
@en
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
@nl
P2860
P921
P356
P1476
T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives
@en
P2093
Vedran Brezar
P2860
P304
P356
10.1155/2011/513210
P5008
P577
2011-07-19T00:00:00Z